Skip to main content

Table 2 IVUS measurements

From: Increased glycated albumin and decreased esRAGE levels in serum are related to negative coronary artery remodeling in patients with type 2 diabetes: an Intravascular ultrasound study

 

NR group

(N = 81)

IR/PR group

(N = 62)

P value

Lesion site

 EEM CSA (mm2)

12.54 ± 4.39

16.50 ± 4.51

< 0.001

 Lumen CSA (mm2)

3.91 ± 1.73

4.08 ± 1.76

0.564

 P&M CSA (mm2)

8.63 ± 3.50

12.42 ± 4.04

< 0.001

 Plaque burden (%)

68.08 ± 10.04

74.71 ± 8.62

< 0.001

Eccentricity index

0.77 ± 0.20

0.74 ± 0.20

0.423

Eccentric lesion, n (%)

70 (86.4)

54 (87.1)

0.906

Proximal reference

 EEM CSA (mm2)

15.67 ± 4.67

15.63 ± 3.76

0.949

 Lumen CSA (mm2)

10.44 ± 3.62

9.75 ± 3.19

0.241

 P&M CSA (mm2)

5.31 ± 2.97

5.87 ± 2.67

0.245

 Plaque burden (%)

31.80 ± 16.39

35.88 ± 17.03

0.150

Distal reference

 EEM CSA (mm2)

14.32 ± 6.70

14.34 ± 4.76

0.983

 Lumen CSA (mm2)

9.07 ± 3.28

9.05 ± 4.06

0.983

 P&M CSA (mm2)

4.79 ± 3.65

5.29 ± 3.42

0.404

 Plaque burden (%)

31.81 ± 15.68

35.81 ± 19.52

0.176

Plaque composition

 Soft, n (%)

18 (22.2)

19 (32.3)

0.178

 Fibrous, n (%)

45 (55.6)

33 (53.2)

0.782

 Calcific (< 90°), n (%)

13 (16.0)

7 (11.3)

0.416

 Mixed, n (%)

5 (6.3)

3 (4.8)

0.718

  1. NR, negative remodeling; IR/PR, intermediate or positive remodeling; CSA, cross sectional area; P&M, Plaque and media; EEM, external elastic membrane